文献速递高血压冠心病血脂与心血管预防

血浆蛋白、血压与心血管疾病的网络孟德尔随机化与观察性研究

Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study.
PubMed 文献 · Eur Heart J · 2026-01-01

本研究利用2007种血浆蛋白的遗传工具开展全蛋白质组孟德尔随机化,评估其对收缩压与舒张压的因果效应,并对与血压强相关的蛋白进一步分析其对冠心病和卒中亚型的影响。研究发现242种蛋白与血压相关,其中48种同时与冠心病或卒中相关,4种获共定位支持;网络孟德尔随机化提示其对冠心病和卒中的效应有30.5%–77.2%经血压介导,UK Biobank观察性分析支持上述结果。

要点

  • 242种血浆蛋白与血压相关,48种同时与冠心病或卒中相关。
  • ACOX1、FGF5、FURIN、MST1获遗传共定位支持(FDR 5%、PP≥70%)。
  • 上述蛋白对冠心病和卒中的效应约30.5%–77.2%经血压介导。

核心结论

  • 研究识别出在血压调控与心血管疾病风险中可能具有因果作用的关键血浆蛋白,并提示血压是其对冠心病和卒中效应的主要介导因素。

研究设计与样本

  • 全蛋白质组孟德尔随机化研究,利用2007种血浆蛋白的遗传工具评估其对收缩压和舒张压的因果效应。
  • 对与血压强相关的蛋白进一步分析其对冠心病和卒中亚型的潜在因果效应,并行网络孟德尔随机化与贝叶斯共定位分析。
  • 在UK Biobank参与者中用线性回归和Cox比例风险模型检验蛋白、血压与 incident CVD 事件的观察性关联。

主要发现

  • 全蛋白质组孟德尔随机化识别242种与血压相关的蛋白,其中48种同时与冠心病或卒中相关。
  • ACOX1、FGF5、FURIN、MST1四种蛋白获遗传共定位分析支持(FDR 5%和PP≥70%)。
  • 遗传预测的FURIN和FGF5与血压及卒中风险强相关,ACOX1、FGF5和MST1对冠心病显示潜在因果效应。
  • 网络孟德尔随机化提示这些蛋白对冠心病和卒中效应的30.5%–77.2%经血压调控介导,观察性分析进一步支持上述发现。

关键数值与推荐

  • 共定位支持标准为FDR 5%和PP≥70%。
  • 网络孟德尔随机化估计经血压介导的冠心病和卒中效应比例为30.5%–77.2%。

临床怎么用

  • 提示血压是部分血浆蛋白致冠心病和卒中效应的重要介导通路,支持以血压为干预靶点的思路。
  • ACOX1、FGF5、FURIN、MST1等蛋白可作为高血压相关心血管病进一步研究的候选靶点。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The biological pathways leading to elevated blood pressure (BP) and subsequent cardiovascular diseases (CVDs) remain incompletely understood. Investigating the proteomic landscape of BP and its overlap with CVD could provide critical insights into the molecular determinants and pathways involved in BP regulation and its subsequent effect on CVD. METHODS: A proteome-wide Mendelian randomization (MR) study was conducted by leveraging genetic instruments from 2007 plasma proteins to assess their causal effects on BP (systolic and diastolic BP). Proteins showing strong associations with BP were further analyzed for potential causal effects on coronary artery disease (CAD) and stroke subtypes. Network MR was performed to estimate the proportion of CVD risk mediated through BP. Bayesian colocalization was applied to determine whether identified associations share common causal variants. Observational associations were examined in UK Biobank participants to assess associations between proteins, BP, and incident CVD events using linear regression and Cox proportional hazard models. RESULTS: Proteome-wide MR identified 242 proteins associated with BP, of which 48 were also linked to CAD or stroke, with four (ACOX1, FGF5, FURIN, MST1) also supported by genetic colocalization analyses (FDR 5% and PP ≥70%). Genetically predicted FURIN and FGF5 were strongly associated with BP and stroke risk, while ACOX1, FGF5, and MST1 exhibited potential causal effects on CAD. Network MR suggested that a substantial proportion of their effect on CAD and stroke (30.5%-77.2%) was mediated through BP regulation. Observational analyses further supported these findings. CONCLUSIONS: This study identifies key plasma proteins with potential causal roles in BP regulation and CVD risk, highlighting BP as a major mediator of their effects on CAD and stroke. These findings provide novel insights into the molecular mechanisms underlying hypertension-related CVD and identify promising protein targets for further investigation.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Meena D, Huang J, Smith A, et al. Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study. Eur Heart J. 2026. PMID: 41065563. doi:10.1093/eurheartj/ehaf725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。